Liming Ge， heads Viscardi's business efforts in the Greater China Market. His responsibilities include marketing， fostering and maintaining VISCARDI's client network in this region. He is also responsible for the origination and execution of various transactions （corporate restructuring， merger & acquisition， private financing， and equity capital market） in conjunction with Viscardi's sector teams. Prior to his current responsibility， Dr.Ge was a member of Viscardi's Health Care & Life Sciences team bringing his over 11 years of rich experience in this sector.
Prior to joining VISCARDI， Dr.Ge was the Chief Scientific Officer （CSO） and a member of the Management Board of EleGene AG as well as the co-founder and Managing Director （CEO） of Xerion Pharmaceuticals AG. Dr.Ge started his career as the Senior Scientist and co-inventor of the HuCAL technology at MorphoSys AG.
Dr.Ge was awarded a PhD degree in Chemistry from Harvard University in Cambridge， Massachusetts and an MBA from European University， Geneva. He received postdoctoral training in molecular biology and antibody engineering from Max-Planck-Institute for Biochemistry， Martinsried.
